跳转至内容
Merck
CN

CS1010

组蛋白去乙酰化酶检测试剂盒,荧光分析法

sufficient for 100 assays (96 well plates)

别名:

HDAC 检测试剂盒

登录 查看公司和协议定价

选择尺寸


关于此项目

EC 号:
UNSPSC代码:
12161503
NACRES:
NA.84
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

用途

sufficient for 100 assays (96 well plates)

质量水平

运输

dry ice

储存温度

−20°C

基因信息

human ... HDAC1(3065)

应用

组蛋白脱乙酰检测试剂盒提供了用于基于两步酶促反应的检测HDAC活性的简单方法。该酶促测定的底物是具有乙酰化赖氨酸残基和结合的荧光基团的取代肽。反应的第一步是通过含HDAC的样品(HeLa细胞提取物、纯化酶等)使乙酰化的赖氨酸侧链脱乙酰化。第二步是通过显影液裂解脱乙酰基的底物并释放游离的高荧光基团。测得的荧光与样品的脱乙酰活性成正比。

生化/生理作用

组蛋白脱乙酰基酶(HDAC)是从组蛋白中去除乙酰基的酶。HDAC是基因表达和基因组功能的重要调节剂。它们与多种人类疾病有关,如几种癌症、神经系统疾病和衰老等。因此,HDAC是治疗干预的相关关键目标。此外,已证明组蛋白脱乙酰基酶抑制剂可作为抗肿瘤剂。

特点和优势

该试剂盒包括快速简便地测量细胞或核提取物中或纯化的酶制剂中HDAC活性所需的所有试剂。此外,该试剂盒还提供HeLa细胞裂解物作为HDAC活性的来源,用于抑制剂筛选或作为阳性对照、HDAC抑制剂(曲古抑菌素A)和实现活性定量的标准品。

分析说明

组蛋白脱乙酰基酶测定试剂盒已经在HeLa、HEK 293T、NIH 3T3和U 973细胞提取物中进行了测试。

仅试剂盒组分

产品编号
说明

  • Assay Buffer 20 mL

  • Developer Solution 1.5 mL

  • HDAC Inhibitor (Trichostatin A), 1 mM 50 μL

  • HDAC Substrate, 20 mM 50 μL

  • HeLa Cell Lysate 500 μL

  • Standard (non-acetylated substrate), 4 mM 50 μL

储存分类代码

10 - Combustible liquids

闪点(°F)

188.6 °F - closed cup

闪点(°C)

87 °C - closed cup

法规信息

高风险级别生物产品--病毒,疫苗等
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Lin Du et al.
Journal of natural products, 77(7), 1753-1757 (2014-07-08)
The cyclic tetrapeptide 1-alaninechlamydocin was purified from a Great Lakes-derived fungal isolate identified as a Tolypocladium sp. Although the planar structure was previously described, a detailed analysis of its spectroscopic data and biological activity are reported here for the first
Ze Yang et al.
Cell research, 20(3), 276-287 (2010-01-27)
LSD1 (KDM1 under the new nomenclature) was the first identified lysine-specific histone demethylase belonging to the flavin-dependent amine oxidase family. Here, we report that AOF1 (KDM1B under the new nomenclature), a mammalian protein related to LSD1, also possesses histone demethylase
Francis Wang Dang et al.
The Journal of biological chemistry, 291(36), 18765-18777 (2016-07-16)
The ubiquitin/proteasome pathway is a well characterized system for degrading intracellular proteins, although many aspects remain poorly understood. There is, for instance, a conspicuous lack of understanding of the site(s) where nuclear proteins are degraded because the subcellular distribution of
Bartosz Bieszczad et al.
Pharmaceuticals (Basel, Switzerland), 14(9) (2021-09-29)
Histone deacetylase (HDAC) inhibitors are a class of drugs used in the cancer treatment. Here, we developed a library of 19 analogues of Vorinostat, an HDAC inhibitor used in lymphomas treatment. In Vorinostat, we replaced the hydrophobic phenyl group with
Jason D Plummer et al.
eLife, 10 (2021-03-31)
Methionine restriction (MR) dramatically extends the healthspan of several organisms. Methionine-restricted rodents have less age-related pathology and increased longevity as compared with controls, and recent studies suggest that humans might benefit similarly. Mechanistically, it is likely that the decreased IGF-1

相关内容

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持